Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained pla...
Saved in:
| Published in | The Lancet (British edition) Vol. 375; no. 9709; pp. 141 - 147 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Kidlington
Elsevier Ltd
09.01.2010
Elsevier Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0140-6736 1474-547X 1474-547X |
| DOI | 10.1016/S0140-6736(09)61752-9 |
Cover
Loading…
| Abstract | Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained placenta.
In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258.
The primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61·3%]
vs placebo 177/285 [62·1%]; relative risk 0·98, 95% CI 0·87–1·12; p=0·84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups.
Umbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta.
WHO, WellBeing of Women, Pakistan Higher Education Commission. |
|---|---|
| AbstractList | Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained placenta.
In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258.
The primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61.3%] vs placebo 177/285 [62.1%]; relative risk 0.98, 95% CI 0.87-1.12; p=0.84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups.
Umbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta.
WHO, WellBeing of Women, Pakistan Higher Education Commission. Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained placenta. In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258. The primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61.3%] vs placebo 177/285 [62.1%]; relative risk 0.98, 95% CI 0.87-1.12; p=0.84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups. Umbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta. WHO, WellBeing of Women, Pakistan Higher Education Commission. Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained placenta. In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258. The primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61·3%] vs placebo 177/285 [62·1%]; relative risk 0·98, 95% CI 0·87–1·12; p=0·84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups. Umbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta. WHO, WellBeing of Women, Pakistan Higher Education Commission. Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained placenta.BACKGROUNDRetained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained placenta.In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258.METHODSIn this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258.The primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61.3%] vs placebo 177/285 [62.1%]; relative risk 0.98, 95% CI 0.87-1.12; p=0.84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups.FINDINGSThe primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61.3%] vs placebo 177/285 [62.1%]; relative risk 0.98, 95% CI 0.87-1.12; p=0.84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups.Umbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta.INTERPRETATIONUmbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta.WHO, WellBeing of Women, Pakistan Higher Education Commission.FUNDINGWHO, WellBeing of Women, Pakistan Higher Education Commission. Summary Background Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained placenta. Methods In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258. Findings The primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61·3%] vs placebo 177/285 [62·1%]; relative risk 0·98, 95% CI 0·87–1·12; p=0·84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups. Interpretation Umbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta. Funding WHO, WellBeing of Women, Pakistan Higher Education Commission. In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258. Findings: The primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61 super(.3%] vs placebo 177/285 [62) super(.)1%]; relative risk 0 super(.98, 95% CI 0) super(.)87-1 super(.12; p=0) super(.)84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups. Interpretation: Umbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta. Funding: WHO, WellBeing of Women, Pakistan Higher Education Commission. |
| Author | Gosakan, Radhika Namayanja, Annette Jafri, Hussain Weeks, Andrew D Vernon, Gillian Hart, Anna Nardin, Juan Mirembe, Florence Alia, Godfrey Raashid, Yasmin Majeed, Tayyaba Carroli, Guillermo Alfirevic, Zarko Fairlie, Fiona |
| Author_xml | – sequence: 1 givenname: Andrew D surname: Weeks fullname: Weeks, Andrew D email: aweeks@liv.ac.uk organization: School of Reproductive and Developmental Medicine, University of Liverpool, Liverpool, UK – sequence: 2 givenname: Godfrey surname: Alia fullname: Alia, Godfrey organization: Department of Obstetrics and Gynaecology, Makerere University, Kampala, Uganda – sequence: 3 givenname: Gillian surname: Vernon fullname: Vernon, Gillian organization: School of Reproductive and Developmental Medicine, University of Liverpool, Liverpool, UK – sequence: 4 givenname: Annette surname: Namayanja fullname: Namayanja, Annette organization: Department of Obstetrics and Gynaecology, Makerere University, Kampala, Uganda – sequence: 5 givenname: Radhika surname: Gosakan fullname: Gosakan, Radhika organization: Jessop Wing, Royal Hallamshire Hospital, Sheffield, UK – sequence: 6 givenname: Tayyaba surname: Majeed fullname: Majeed, Tayyaba organization: Department of Obstetrics and Gynaecology, Lady Willingdon Hospital, Lahore, Pakistan – sequence: 7 givenname: Anna surname: Hart fullname: Hart, Anna organization: Faculty of Health and Social Care, University of Central Lancashire, Preston, UK – sequence: 8 givenname: Hussain surname: Jafri fullname: Jafri, Hussain organization: Department of Obstetrics and Gynaecology, Lady Willingdon Hospital, Lahore, Pakistan – sequence: 9 givenname: Juan surname: Nardin fullname: Nardin, Juan organization: Centro Rosarino de Estudios Perinatales (CREP), Rosario, Argentina – sequence: 10 givenname: Guillermo surname: Carroli fullname: Carroli, Guillermo organization: Centro Rosarino de Estudios Perinatales (CREP), Rosario, Argentina – sequence: 11 givenname: Fiona surname: Fairlie fullname: Fairlie, Fiona organization: Jessop Wing, Royal Hallamshire Hospital, Sheffield, UK – sequence: 12 givenname: Yasmin surname: Raashid fullname: Raashid, Yasmin organization: Department of Obstetrics and Gynaecology, Lady Willingdon Hospital, Lahore, Pakistan – sequence: 13 givenname: Florence surname: Mirembe fullname: Mirembe, Florence organization: Department of Obstetrics and Gynaecology, Makerere University, Kampala, Uganda – sequence: 14 givenname: Zarko surname: Alfirevic fullname: Alfirevic, Zarko organization: School of Reproductive and Developmental Medicine, University of Liverpool, Liverpool, UK |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22310142$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20004013$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkm1rFDEUhQep2Bf9CUoQii04mkwyyUZRkeIbFARrwW8hk7mDqdlkTTLFxT9vZndtYUHWT7mE5xySe85hteeDh6p6SPAzggl_foEJwzUXlJ9gecqJaJta3qkOCBOsbpn4tlcd3CD71WFKVxhjxnF7r9pvphETelD9vpx31lmjHboG61H4tczBlGEIEeXvgHIEnefgMwoDipC19dCjhdOm3Gl08gUc6AToIo_98vQF0qgPY-eg7pz1_VMUte_D3KYiMsHnGJwrY45Wu_vV3UG7BA8251F1-f7d17OP9fnnD5_O3p7XpuVNrrkmnaZC8hnFMEDfaMylBCEIppzO-rZlbCj_lx1psZBYdoJJ4AM1jOpBtPSoerL2XcTwc4SUVXmPAee0hzAmNROSCcFavJMUlPKWlyUW8vEWeRXG6Ms3FJESMzYjtECPNtDYzaFXi2jnOi7V3_UX4HgD6FQiGMqyjE23XENL1qwpXLvmTAwpRRhuEILVVAe1qoOaslZYqlUdlCy6l1s6Y7POdgpCW7dT_WathhLOtYWokrHgDfQ2gsmqD3anw-stB1NaMbXtBywh3a5MpUbhtcnkgeXKYTJ49W-D_3jAHxGm9GU |
| CODEN | LANCAO |
| CitedBy_id | crossref_primary_10_1007_s00129_010_2739_6 crossref_primary_10_1016_j_ejogrb_2017_05_028 crossref_primary_10_1155_2014_274651 crossref_primary_10_1111_aogs_12848 crossref_primary_10_1155_2012_594140 crossref_primary_10_1016_j_jgyn_2014_09_025 crossref_primary_10_1016_j_jgyn_2014_09_026 crossref_primary_10_1016_j_tjog_2013_01_010 crossref_primary_10_1097_AOG_0000000000000697 crossref_primary_10_3109_01443615_2010_531301 crossref_primary_10_5317_wjog_v3_i3_124 crossref_primary_10_1016_S0992_5945_10_70381_0 crossref_primary_10_1186_1471_2393_14_37 crossref_primary_10_1016_S1773_035X_10_70599_2 crossref_primary_10_1002_14651858_CD001337_pub3 crossref_primary_10_1002_14651858_CD001337_pub2 crossref_primary_10_1097_AOG_0b013e3181edac6b crossref_primary_10_1016_j_ijgo_2010_08_021 crossref_primary_10_1016_j_ijgo_2013_03_029 crossref_primary_10_1007_s00404_010_1785_6 crossref_primary_10_1111_j_1600_0412_2012_01506_x crossref_primary_10_1515_jpm_2021_0632 crossref_primary_10_1002_14651858_CD009854 crossref_primary_10_1155_2012_321207 crossref_primary_10_1186_s12884_023_06097_0 crossref_primary_10_1016_j_ajog_2020_06_044 crossref_primary_10_1016_j_ogrm_2013_04_002 crossref_primary_10_1016_S1090_798X_10_79278_X crossref_primary_10_1111_jog_12702 crossref_primary_10_1111_j_1447_0756_2012_01974_x |
| Cites_doi | 10.1186/1745-6215-7-13 10.3109/01443618809008808 10.1016/S0029-7844(97)00622-4 10.1016/S0301-2115(01)00592-9 10.1016/0002-9378(91)90685-K 10.1002/14651858.CD001337 10.1016/S0024-3205(00)00451-3 10.1016/j.bpobgyn.2008.07.005 10.1016/S0002-9378(11)90788-1 10.1080/00016340601088570 10.1016/0002-9378(89)90254-8 10.1016/S0002-9378(12)90821-2 10.1111/j.1471-0528.2005.00681.x 10.3109/01443618609112286 10.1016/0002-9378(87)90372-3 10.1111/j.1471-0528.1998.tb10049.x 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.0.CO;2-H |
| ContentType | Journal Article |
| Copyright | 2010 Elsevier Ltd Elsevier Ltd 2015 INIST-CNRS Copyright 2010 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Jan 9-Jan 15, 2010 |
| Copyright_xml | – notice: 2010 Elsevier Ltd – notice: Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright 2010 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Jan 9-Jan 15, 2010 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U S0X 7X8 7U1 |
| DOI | 10.1016/S0140-6736(09)61752-9 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional Biological Sciences Consumer Health Database (ProQuest) Health & Medical Collection (Alumni) Healthcare Administration Database (ProQuest) Medical Database Psychology Database (ProQuest) Research Library Science Database (ProQuest) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database (ProQuest) Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic Risk Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) MEDLINE - Academic Risk Abstracts |
| DatabaseTitleList | MEDLINE ProQuest One Psychology MEDLINE - Academic Risk Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Education |
| EISSN | 1474-547X |
| EndPage | 147 |
| ExternalDocumentID | 1939261711 20004013 22310142 10_1016_S0140_6736_09_61752_9 S0140673609617529 1_s2_0_S0140673609617529 |
| Genre | Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Uganda British Isles Pakistan |
| GeographicLocations_xml | – name: Uganda – name: British Isles – name: Pakistan |
| GrantInformation | WHO, WellBeing of Women, Pakistan Higher Education Commission. |
| GroupedDBID | --- --K --M .1- .55 .CO .FO .GJ 04C 0R~ 123 1B1 1P~ 1RT 1~5 29L 3EH 3O- 4.4 41~ 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 8WZ 9JM A6W AABNK AAEDT AAEDW AAEJM AAIKJ AAKAS AAKOC AALRI AAMRU AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABDBF ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUWG ABWVN ACGFS ACGOD ACIEU ACIUM ACPRK ACRLP ACRPL ACUHS ACVFH ADBBV ADCNI ADMUD ADNMO ADXHL ADZCM AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFFNX AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGCQF AGHFR AGQPQ AHHHB AHMBA AHQJS AIGII AIIUN AITUG AJJEV AJRQY AJUYK AKBMS AKRWK AKVCP AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI ARTTT ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 D0S DU5 DWQXO EAP EAS EAU EAZ EBC EBD EBS EBU EFJIC EFKBS EGS EHN EIHBH EJD EMB EMK EMOBN ENC EO8 EO9 EP2 EP3 EPL EPS EPT ESX EVS EWM EX3 F5P FD8 FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IHE J1W J5H K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M41 M7P MJL MO0 MVM N9A NAPCQ O-L O9- OD. OO~ OVD OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ PUEGO Q~Q R2- ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ SV3 T5K TEORI TH9 TLN TWZ UAP UBE UHU UKHRP UQL UV1 WOQ WOW WUQ X7M XAX XDU XPP YYM YYQ Z5R ZGI ZMT ZXP ZY4 ~G0 3V. 88A AACTN AAYOK ABTAH ACRZS AFCTW AFKWA AJOXV ALIPV AMFUW M0L PKN RIG SDF ABLVK ABYKQ AHPSJ AJBFU NHB XFK Y6R ZA5 AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7QL 7QP 7TK 7U7 7U9 7XB 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 7U1 |
| ID | FETCH-LOGICAL-c562t-6a1ba3796830efed2a0699e77103638d5544f1759b1507909b749e6f3c43af753 |
| IEDL.DBID | BENPR |
| ISSN | 0140-6736 1474-547X |
| IngestDate | Thu Sep 04 18:08:31 EDT 2025 Thu Sep 04 15:30:46 EDT 2025 Sat Aug 23 12:31:45 EDT 2025 Thu Apr 03 06:49:52 EDT 2025 Mon Jul 21 09:15:46 EDT 2025 Tue Jul 01 02:45:26 EDT 2025 Thu Apr 24 22:58:21 EDT 2025 Fri Feb 23 02:30:11 EST 2024 Sun Feb 23 10:19:31 EST 2025 Tue Aug 26 16:32:35 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9709 |
| Keywords | Medicine Treatment Pregnancy disorders Oxytocin Retention of placental fragments Double blind study Delivery disorders Clinical trial Umbilical vein Randomized controlled trial Release |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright 2010 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c562t-6a1ba3796830efed2a0699e77103638d5544f1759b1507909b749e6f3c43af753 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 20004013 |
| PQID | 199044813 |
| PQPubID | 40246 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_879477450 proquest_miscellaneous_733656460 proquest_journals_199044813 pubmed_primary_20004013 pascalfrancis_primary_22310142 crossref_primary_10_1016_S0140_6736_09_61752_9 crossref_citationtrail_10_1016_S0140_6736_09_61752_9 elsevier_sciencedirect_doi_10_1016_S0140_6736_09_61752_9 elsevier_clinicalkeyesjournals_1_s2_0_S0140673609617529 elsevier_clinicalkey_doi_10_1016_S0140_6736_09_61752_9 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-01-09 |
| PublicationDateYYYYMMDD | 2010-01-09 |
| PublicationDate_xml | – month: 01 year: 2010 text: 2010-01-09 day: 09 |
| PublicationDecade | 2010 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington – name: England – name: London |
| PublicationTitle | The Lancet (British edition) |
| PublicationTitleAlternate | Lancet |
| PublicationYear | 2010 |
| Publisher | Elsevier Ltd Elsevier Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier – name: Elsevier Limited |
| References | Vernon, Alfirevic, Weeks (bib8) 2006; 7 Carroli, Belizan, Grant, Gonzalez, Campodonico, Bergel (bib5) 1998; 105 Gazvani, Luckas, Drakeley, Emery, Alfirevic, Walkinshaw (bib12) 1998; 91 Carroli, Bergel (bib4) 2001; 4 Pipingas, Hofmeyr, Sesel (bib6) 1993; 168 (bib7) 1997 Herman, Weinraub, Bukovsky (bib3) 1993; 168 Calderale, Dalle, Franzoi, Vitalini (bib10) 1994; 16 Weeks (bib1) 2008; 22 Hansen, Jorgensen, Dueholm, Hansen (bib13) 1987; 149 Malek, Blann, Mattison (bib21) 1996; 5 Huber, Wildschut, Boer, Kleiverda, Hoek (bib14) 1991; 164 Rogers, Yuen, Wong (bib16) 2007; 86 Weeks, Mirembe (bib2) 2002; 102 Frappell, Pearce, McParland (bib11) 1988; 8 Selinger, Mackenzie, Dunlop, James (bib17) 1986; 7 (bib20) 2009 Wilken-Jensen, Strøm, Nielsen, Rosenkilde-Gram (bib19) 1989; 161 Weeks, Mirembe, Alfirevic (bib9) 2005; 112 Kristiansen, Frost, Kaspersen, Moller (bib15) 1987; 156 Sivalingam, Surinder (bib18) 2001; 56 Yamahara, Nomura, Suzuki (bib22) 2000; 66 Weeks (10.1016/S0140-6736(09)61752-9_bib1) 2008; 22 (10.1016/S0140-6736(09)61752-9_bib7) 1997 Herman (10.1016/S0140-6736(09)61752-9_bib3) 1993; 168 Rogers (10.1016/S0140-6736(09)61752-9_bib16) 2007; 86 (10.1016/S0140-6736(09)61752-9_bib20) 2009 Huber (10.1016/S0140-6736(09)61752-9_bib14) 1991; 164 Weeks (10.1016/S0140-6736(09)61752-9_bib9) 2005; 112 Selinger (10.1016/S0140-6736(09)61752-9_bib17) 1986; 7 Wilken-Jensen (10.1016/S0140-6736(09)61752-9_bib19) 1989; 161 Pipingas (10.1016/S0140-6736(09)61752-9_bib6) 1993; 168 Weeks (10.1016/S0140-6736(09)61752-9_bib2) 2002; 102 Malek (10.1016/S0140-6736(09)61752-9_bib21) 1996; 5 Carroli (10.1016/S0140-6736(09)61752-9_bib5) 1998; 105 Sivalingam (10.1016/S0140-6736(09)61752-9_bib18) 2001; 56 Carroli (10.1016/S0140-6736(09)61752-9_bib4) 2001; 4 Kristiansen (10.1016/S0140-6736(09)61752-9_bib15) 1987; 156 Frappell (10.1016/S0140-6736(09)61752-9_bib11) 1988; 8 Yamahara (10.1016/S0140-6736(09)61752-9_bib22) 2000; 66 Calderale (10.1016/S0140-6736(09)61752-9_bib10) 1994; 16 Gazvani (10.1016/S0140-6736(09)61752-9_bib12) 1998; 91 Vernon (10.1016/S0140-6736(09)61752-9_bib8) 2006; 7 Hansen (10.1016/S0140-6736(09)61752-9_bib13) 1987; 149 20004012 - Lancet. 2010 Jan 9;375(9709):98-9 |
| References_xml | – volume: 4 year: 2001 ident: bib4 article-title: Umbilical vein injection for management of retained placenta publication-title: Cochrane Database Syst Rev – volume: 56 start-page: 451 year: 2001 end-page: 459 ident: bib18 article-title: Is there a place for intra-umbilical oxytocin for the management of retained placenta? publication-title: Med J Malaysia – volume: 112 start-page: 1458 year: 2005 ident: bib9 article-title: The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta publication-title: BJOG – volume: 86 start-page: 48 year: 2007 end-page: 54 ident: bib16 article-title: Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for the management of adherent placenta publication-title: Acta Obstet Gynecol – volume: 22 start-page: 1103 year: 2008 end-page: 1117 ident: bib1 article-title: The retained placenta publication-title: Best Pract Res Clin Obstet Gynaecol – volume: 161 start-page: 155 year: 1989 end-page: 156 ident: bib19 article-title: Removing placenta by oxytocin—a controlled study publication-title: Am J Obstet Gynecol – volume: 168 start-page: 1496 year: 1993 end-page: 1499 ident: bib3 article-title: Dynamic ultrasonographic imaging of the third stage of labor: new perspectives into third stage mechanism publication-title: Am J Obstet Gynecol – year: 2009 ident: bib20 publication-title: WHO guidelines for the management of postpartum haemorrhage and retained placenta – volume: 16 start-page: 283 year: 1994 end-page: 286 ident: bib10 article-title: Is intraumbilical vein administration with oxytocin useful for the treatment of retained placenta? publication-title: Giornale Italiano di Ostetricia e Ginecologia – volume: 164 start-page: 1216 year: 1991 end-page: 1219 ident: bib14 article-title: Umbilical vein administration of oxytocin for the mangement of retained placenta: is it effective? publication-title: Am J Obstet Gynecol – volume: 7 start-page: 115 year: 1986 end-page: 117 ident: bib17 article-title: Intra-umbilical vein oxytocin in the management of retained placenta. A double blind placebo controlled study publication-title: J Obstet Gynaecol – volume: 168 start-page: 793 year: 1993 end-page: 795 ident: bib6 article-title: Umbilical vessel oxytocin administration for retained placenta: in-vitro study of various infusion techniques publication-title: Am J Obstet Gynecol – volume: 149 start-page: 3318 year: 1987 end-page: 3319 ident: bib13 article-title: Intraumbilical oxytocin in the treatment of retained placenta publication-title: Ugeskr Laeger – volume: 156 start-page: 979 year: 1987 end-page: 980 ident: bib15 article-title: The effect of oxytocin injection into the umbilical vein for the management of retained placenta publication-title: Am J Obstet Gynecol – volume: 66 start-page: 1401 year: 2000 end-page: 1410 ident: bib22 article-title: Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy publication-title: Life Sci – volume: 105 start-page: 179 year: 1998 end-page: 185 ident: bib5 article-title: Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial publication-title: Br J Obstet Gynaecol – volume: 91 start-page: 203 year: 1998 end-page: 207 ident: bib12 article-title: Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial publication-title: Obstet Gynecol – year: 1997 ident: bib7 publication-title: A charter for ethical research in maternity care – volume: 8 start-page: 322 year: 1988 end-page: 324 ident: bib11 article-title: Intra-umbilical vein oxytocin in the management of retained placenta: a random, prospective, double blind, placebo controlled study publication-title: J Obstet Gynaecol – volume: 102 start-page: 109 year: 2002 end-page: 110 ident: bib2 article-title: The retained placenta—new insights into an old problem (editorial) publication-title: Eur J Obstet Gynecol Reprod Biol – volume: 5 start-page: 245 year: 1996 end-page: 255 ident: bib21 article-title: Human placental transport of oxytocin publication-title: J Matern Fetal Med – volume: 7 start-page: 13 year: 2006 ident: bib8 article-title: Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] publication-title: Trials – volume: 7 start-page: 13 year: 2006 ident: 10.1016/S0140-6736(09)61752-9_bib8 article-title: Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258] publication-title: Trials doi: 10.1186/1745-6215-7-13 – volume: 8 start-page: 322 year: 1988 ident: 10.1016/S0140-6736(09)61752-9_bib11 article-title: Intra-umbilical vein oxytocin in the management of retained placenta: a random, prospective, double blind, placebo controlled study publication-title: J Obstet Gynaecol doi: 10.3109/01443618809008808 – volume: 91 start-page: 203 year: 1998 ident: 10.1016/S0140-6736(09)61752-9_bib12 article-title: Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial publication-title: Obstet Gynecol doi: 10.1016/S0029-7844(97)00622-4 – volume: 102 start-page: 109 year: 2002 ident: 10.1016/S0140-6736(09)61752-9_bib2 article-title: The retained placenta—new insights into an old problem (editorial) publication-title: Eur J Obstet Gynecol Reprod Biol doi: 10.1016/S0301-2115(01)00592-9 – volume: 164 start-page: 1216 year: 1991 ident: 10.1016/S0140-6736(09)61752-9_bib14 article-title: Umbilical vein administration of oxytocin for the mangement of retained placenta: is it effective? publication-title: Am J Obstet Gynecol doi: 10.1016/0002-9378(91)90685-K – volume: 56 start-page: 451 year: 2001 ident: 10.1016/S0140-6736(09)61752-9_bib18 article-title: Is there a place for intra-umbilical oxytocin for the management of retained placenta? publication-title: Med J Malaysia – volume: 4 year: 2001 ident: 10.1016/S0140-6736(09)61752-9_bib4 article-title: Umbilical vein injection for management of retained placenta publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD001337 – volume: 66 start-page: 1401 year: 2000 ident: 10.1016/S0140-6736(09)61752-9_bib22 article-title: Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy publication-title: Life Sci doi: 10.1016/S0024-3205(00)00451-3 – volume: 22 start-page: 1103 year: 2008 ident: 10.1016/S0140-6736(09)61752-9_bib1 article-title: The retained placenta publication-title: Best Pract Res Clin Obstet Gynaecol doi: 10.1016/j.bpobgyn.2008.07.005 – year: 2009 ident: 10.1016/S0140-6736(09)61752-9_bib20 – volume: 168 start-page: 1496 year: 1993 ident: 10.1016/S0140-6736(09)61752-9_bib3 article-title: Dynamic ultrasonographic imaging of the third stage of labor: new perspectives into third stage mechanism publication-title: Am J Obstet Gynecol doi: 10.1016/S0002-9378(11)90788-1 – volume: 86 start-page: 48 year: 2007 ident: 10.1016/S0140-6736(09)61752-9_bib16 article-title: Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for the management of adherent placenta publication-title: Acta Obstet Gynecol doi: 10.1080/00016340601088570 – year: 1997 ident: 10.1016/S0140-6736(09)61752-9_bib7 – volume: 161 start-page: 155 year: 1989 ident: 10.1016/S0140-6736(09)61752-9_bib19 article-title: Removing placenta by oxytocin—a controlled study publication-title: Am J Obstet Gynecol doi: 10.1016/0002-9378(89)90254-8 – volume: 168 start-page: 793 year: 1993 ident: 10.1016/S0140-6736(09)61752-9_bib6 article-title: Umbilical vessel oxytocin administration for retained placenta: in-vitro study of various infusion techniques publication-title: Am J Obstet Gynecol doi: 10.1016/S0002-9378(12)90821-2 – volume: 112 start-page: 1458 year: 2005 ident: 10.1016/S0140-6736(09)61752-9_bib9 article-title: The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta publication-title: BJOG doi: 10.1111/j.1471-0528.2005.00681.x – volume: 7 start-page: 115 year: 1986 ident: 10.1016/S0140-6736(09)61752-9_bib17 article-title: Intra-umbilical vein oxytocin in the management of retained placenta. A double blind placebo controlled study publication-title: J Obstet Gynaecol doi: 10.3109/01443618609112286 – volume: 156 start-page: 979 year: 1987 ident: 10.1016/S0140-6736(09)61752-9_bib15 article-title: The effect of oxytocin injection into the umbilical vein for the management of retained placenta publication-title: Am J Obstet Gynecol doi: 10.1016/0002-9378(87)90372-3 – volume: 105 start-page: 179 year: 1998 ident: 10.1016/S0140-6736(09)61752-9_bib5 article-title: Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial publication-title: Br J Obstet Gynaecol doi: 10.1111/j.1471-0528.1998.tb10049.x – volume: 5 start-page: 245 year: 1996 ident: 10.1016/S0140-6736(09)61752-9_bib21 article-title: Human placental transport of oxytocin publication-title: J Matern Fetal Med doi: 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.0.CO;2-H – volume: 149 start-page: 3318 year: 1987 ident: 10.1016/S0140-6736(09)61752-9_bib13 article-title: Intraumbilical oxytocin in the treatment of retained placenta publication-title: Ugeskr Laeger – volume: 16 start-page: 283 year: 1994 ident: 10.1016/S0140-6736(09)61752-9_bib10 article-title: Is intraumbilical vein administration with oxytocin useful for the treatment of retained placenta? publication-title: Giornale Italiano di Ostetricia e Ginecologia – reference: 20004012 - Lancet. 2010 Jan 9;375(9709):98-9 |
| SSID | ssj0004605 |
| Score | 2.1478279 |
| Snippet | Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental... Summary Background Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could... In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 141 |
| SubjectTerms | Adult Anesthesia, General - utilization Biological and medical sciences Blood Pressure Blood Transfusion - utilization Clinical trials commissions Delivery. Postpartum. Lactation Diseases of mother, fetus and pregnancy Disorders Double-Blind Method Education Female General aspects Gynecology. Andrology. Obstetrics Hemoglobins - analysis Human subjects Humans Induced labor Injections, Intravenous Internal Medicine Medical instruments Medical sciences Meta-analysis Oxytocics - therapeutic use Oxytocin - therapeutic use Pakistan - epidemiology Placenta, Retained - therapy Postpartum Hemorrhage - epidemiology Pregnancy Pregnancy. Fetus. Placenta Side effects Studies Systematic review Teaching hospitals Uganda - epidemiology Umbilical Veins United Kingdom - epidemiology Veins & arteries |
| Title | Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0140673609617529 https://www.clinicalkey.es/playcontent/1-s2.0-S0140673609617529 https://dx.doi.org/10.1016/S0140-6736(09)61752-9 https://www.ncbi.nlm.nih.gov/pubmed/20004013 https://www.proquest.com/docview/199044813 https://www.proquest.com/docview/733656460 https://www.proquest.com/docview/879477450 |
| Volume | 375 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1dixMxFA1uCyKI-G1dLXnwYReMm0wyH_FF1mWXxWUXqRb7FpJJBoQ6U52puPjnvZnJTBFa15dS2jmTaW7uvSfNSS5Cr5Kc65xzQTKpHRGZMETS2JEidRToq2Em9buRL6-S87n4sIgXQZtTB1llHxPbQG2r3P9HfsQgbMJUgvF3q-_EF43yi6uhgsYeGkMEzuIRGr8_vfo427YxstW4b7bwHH0aPjyg8hDyeBwRuSs53V3pGrqs6Gpd7CajbVI6u4_uBTaJjzvzP0C3XPkQ3b4M6-WP0O_5Ny9-hZvin-5riatf1w1Yo8RAVTFQPzzozHFVYC89BJjFrVCrbDQ-mEFWgjyHvdzw-vAt1thWa7N0xAA9ta8xPKqtYKgAKIjel_C2LQXyGM3PTj-fnJNQboHkQIIakmhmNE9lknHqCmcjTRMpXQochIOXWiAeooB-ksaTSEmlSYV0ScFzwXUB054naFRWpXuGsOZwC54VgtlY5JZnpshtwnIe0fYEtgkSfT-rPJxF7ktiLNUW0RmVqjWPkhP0ZoCtusM4bgIkvRFVv9MUYqOCdHETMN0GdHXw8FoxVUeKdmgP9qVzAArIbEAGEtORk_9pdPrXOBt-Y-RJOBPQbfv9wFObB-kdY4Lw8C0Y3i_86NJV61r5Iy_jBJxh9yUZxGWYCcRwydNuRG9a944EM4Xn_2x9H93phBWMUPkCjZofa_cS-FpjpmgvXaTwmp2wKRofX8y-XEyDp_4BGZk6iw |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB5KCyqIeHet1nlQaMFpk8zkMoKIl5at7S5Su9C3cZJMoLBNVrOrLv4m_6Pf5LYIu9aXvoVNvkw25_ZN5pw5hDwPEq4TzgWLpDZMRCJm0vENy0LjgL7GbhzaauTBMOiPxMcz_2yN_G5rYWxaZesTK0edFon9Rr7nwm1iKuHyN5OvzDaNsourbQeNWiuOzPwHZmzl68MPEO8LzzvYP33fZ01TAZYg1E9ZoN1Y81AGEXdMZlJPO4GUJkSk5dDFFOFVZIipMrZUSToyDoU0QcYTwXUW2iYR8PgbYBkSRrTxbn_46WRZIWaVU78oGdr73P247cgd8AbfY3JVMLw50SVElNW9NVaT3yoIHtwmtxr2St_W6naHrJn8Lrk2aNbn75FfowubbIub0u_mPKfFz_kU0s8pqDEF1aRdXjstMmpTHQFLaZUYlk813T5BFERcpTa9cb7zimqaFrN4bFgMOpy-pHjUtIBqAtQk2Y9xWLUeuU9GVyKJB2Q9L3LziFDNcQseZcJNfZGkPIqzJA3chHtOteNbj4j2Pauk2fvctuAYqyVJbo5UlXiU7JHdDjapN_-4DBC0QlRtZSt8sUJ4ugwYLgOasvEopXJV6SmnRluwbdUDKJBRh2xIU02G_mfQrb_0rPuPniX9rsBr22wVTy0epDXEHqHdWQjeLjTp3BSzUtktNv0AxrD6kghxADMPH5c8rDV6Mbo1JMxMHv9z9Gfkev90cKyOD4dHm-RGndThMkc-IevTbzPzFFxxGm81FkrJl6t2Cn8A0Kxx4Q |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxQxFA6lQhFEvLtWax4UWjBuMslcIohI69JaW0Rd6FuaTBIQ1pnV2VUXf5n_zpO5LcKu9aVvw858k9k5J-d8mXzJQehJknOdcy5IJrUjIhOGSBo74lNHgb4aZtKwGvnkNDkci7dn8dkG-t2thQmyyi4m1oHalnn4Rj5kEDZhKMH40LeqiPcHo1fTryQUkAoTrV01jcZDjt3iB4zeqpdHB2Dqp1E0evNp_5C0BQZIDml_RhLNjOapTDJOnXc20jSR0qWQdTn4pYVUKzzkV2kCbZJUmlRIl3ieC659GgpGQPS_kvI0C1Ujsn22aklmra5fLh4afux_3KVyDxhEHBG5Li1em-oKjOWbKhvraXCdDkc30PWWx-LXjePdRBuuuIW2TtqZ-tvo1_hLkN3CTfF397nA5c_FDPygwECSMZBO3CvccelxED0CzOJaIlbMNN79APkQMiwOQsfF3gussS3nZuKIAWJsn2F4VFuCkwKoldtP4LAuQnIHjS_FDnfRZlEW7j7CmsMteOYFs7HILc-Mz23Cch7Reu-3ARLde1Z5uwt6KMYxUSvkblSq2jxKDtDzHjZttgG5CJB0RlTdGleIygoS1UXAdBXQVW1sqRRTVaRogw7gULQHoIDMemRLnxpa9D-N7vzlZ_1_jAL9ZwJe23bneGr5IF2XHCDcnwXDhyknXbhyXqmw2WacQGdYf0kGGQHGIDFccq_x6GXroSPBGOXBP1t_jLYgFKh3R6fH2-hqo-5ghMqHaHP2be4eAWmcmZ26e2J0ftnx4A-5bHRz |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Umbilical+vein+oxytocin+for+the+treatment+of+retained+placenta+%28Release+Study%29%3A+a+double-blind%2C+randomised+controlled+trial&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Weeks%2C+Andrew+D&rft.au=Alia%2C+Godfrey&rft.au=Vernon%2C+Gillian&rft.au=Namayanja%2C+Annette&rft.date=2010-01-09&rft.issn=0140-6736&rft.volume=375&rft.issue=9709&rft.spage=141&rft.epage=147&rft_id=info:doi/10.1016%2FS0140-6736%2809%2961752-9&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S0140_6736_09_61752_9 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01406736%2FS0140673610X61086%2Fcov150h.gif |